Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice - Li - 2015 - Journal of Neurochemistry - Wiley Online Library
Mechanisms by Which Glucagon-Like-Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Reduce Cardiovascular Risk in Adults With Type 2 Diabetes Mellitus - Canadian Journal of Diabetes
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
Comparative effectiveness of liraglutide in the treatment of type 2 di | DMSO
Neuroprotective and anti‐apoptotic effects of liraglutide on SH‐SY5Y cells exposed to methylglyoxal stress - Sharma - 2014 - Journal of Neurochemistry - Wiley Online Library
The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis - ScienceDirect
Frontiers | GLP-1 based therapeutics: simultaneously combating T2DM and obesity | Neuroscience
The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways | JACC: Basic to Translational Science
Liraglutide, a glucagon-like peptide-1 receptor agonist, suppresses osteoclastogenesis through the inhibition of NF-κB and MAPK pathways via GLP-1R - ScienceDirect
Effective Switch From Twice-Daily Pre-Mixed Insulin 50/50 to Liraglutide to Achieve a Good Glycemic Control in Type 2 Diabetes | Yanai | Journal of Medical Cases
Proposed signaling transduction of liraglutide. GLP-1R = glucagon-like... | Download Scientific Diagram
Glucagon-like peptide-1 (GLP-1) AGONIST - Incretin Mimetics - GlobalRPH
Diabetes & Metabolism Journal
Liraglutide – Next-Generation Antidiabetic Medication - Clinical Trials Arena
Mechanism of action of antiobesity drugs. 5-HT2C-R: 5-hydroxytryptamine... | Download Scientific Diagram
Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists in: Journal of Endocrinology Volume 236 Issue 1 (2018)
Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics. - Abstract - Europe PMC
Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies - Metabolism - Clinical and Experimental
Recent updates on GLP-1 agonists: Current advancements & challenges - ScienceDirect
Neural effects of gut‐ and brain‐derived glucagon‐like peptide‐1 and its receptor agonist - Katsurada - 2016 - Journal of Diabetes Investigation - Wiley Online Library
![PDF] Incretins and the specific mechanism of action of liraglutide, the first applicable human glucagon-like peptide 1 analog in the treatment of type 2 diabetes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0b52cfb7fea47b6f43bf069587efbee837b789a6/2-Figure1-1.png "PDF] Incretins and the specific mechanism of action of liraglutide, the first applicable human glucagon-like peptide 1 analog in the treatment of type 2 diabetes | Semantic Scholar")
PDF] Incretins and the specific mechanism of action of liraglutide, the first applicable human glucagon-like peptide 1 analog in the treatment of type 2 diabetes | Semantic Scholar
Effects of liraglutide (GLP-1 receptor agonist) – Efficacy and Adverse... | Download Scientific Diagram
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 - ScienceDirect
Dipeptidyl peptidase-4 inhibitor Glucagon-like peptide-1 receptor agonist Liraglutide Dulaglutide, others, angle, text, pharmaceutical Drug png | PNGWing
